Ycanth (Cantharidin) Revolutionizes Molluscum Contagiosum Treatment with FDA Approval
XTalks
AUGUST 7, 2023
has received US Food and Drug Administration (FDA) approval for treating molluscum contagiosum in adult and pediatric patients aged two years and older in the US. Formerly known as VP-102, Ycanth is the first cantharidin formulation approved for this purpose. Another noteworthy contender is Novan Inc.’s
98 
Let's personalize your content